Identification of druggable oncogenic gene fusions and a novel mechanism of drug resistance in lung cancer

被引:0
|
作者
Nakaoku, Takashi [1 ]
Kohno, Takashi [1 ,2 ]
机构
[1] Natl Canc Ctr Res, Div Genome Biol, Tokyo, Japan
[2] Natl Canc Ctr, EPOC, Div Translat Genom, Tokyo, Japan
来源
CANCER SCIENCE | 2018年 / 109卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
YIA-7
引用
收藏
页码:363 / 363
页数:1
相关论文
共 50 条
  • [1] Novel oncogenic gene fusions in prostate cancer
    不详
    CANCER BIOLOGY & THERAPY, 2007, 6 (09) : 1337 - 1338
  • [2] Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions
    Li, Binghao
    Qu, Hao
    Zhang, Jing
    Pan, Weibo
    Liu, Meng
    Yan, Xiaobo
    Huang, Xin
    He, Xuexin
    Lin, Dong
    Liu, Sisi
    Guan, Ruting
    Wu, Yong
    Ou, Qiuxiang
    Bao, Hua
    Xu, Youbin
    Wu, Xue
    Shao, Yang
    Lin, Nong
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [3] Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions
    Binghao Li
    Hao Qu
    Jing Zhang
    Weibo Pan
    Meng Liu
    Xiaobo Yan
    Xin Huang
    Xuexin He
    Dong Lin
    Sisi Liu
    Ruting Guan
    Yong Wu
    Qiuxiang Ou
    Hua Bao
    Youbin Xu
    Xue Wu
    Yang Shao
    Nong Lin
    npj Precision Oncology, 5
  • [4] Identification of a novel oncogenic receptor tyrosine kinase ELSERT as a new biomarker and a druggable target for lung and esophageal cancer
    Daigo, Yataro
    Nishino, Ryohei
    Takano, Atsushi
    Tsuchiya, Eiju
    Nakamura, Yusuke
    CANCER RESEARCH, 2009, 69
  • [5] Identification of oncogenic gene fusions in primary colon cancers
    van den Braak, Robert R. Coebergh
    Kloosterman, Wigard P.
    Pieterse, Mark
    van Roosmalen, Markus
    Sieuwerts, Anieta M.
    Stangl, Christina
    Brunekreef, Ronne
    Lalmahomed, Zarina S.
    Ooft, Salo
    van Galen, Anne
    Smid, Marcel
    Lefebvre, Armel
    Zwartkruis, Fried J.
    Martens, John W.
    Foekens, John A.
    Biermann, Katharina
    Koudijs, Marco J.
    IJzermans, Jan N.
    Voest, Emile E.
    CANCER RESEARCH, 2017, 77
  • [6] Second gene mutation explains mechanism of lung cancer drug resistance
    Lemmens, N
    PHARMACOGENOMICS, 2005, 6 (02) : 101 - 101
  • [7] Gene fusions in lung cancer
    Beer, David G.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [8] Identification of oncogenic gene fusions in triple-negative breast cancer metastatic to the brain
    Gonzalez-Ericsson, P.
    Lehmann, B.
    Mobley, B.
    Chen, Y-Y
    Pietenpol, J.
    Sanders, M. E.
    CANCER RESEARCH, 2019, 79 (04)
  • [9] Oncogenic gene fusions in cancer: from biology to therapy
    Stephen V. Liu
    Misako Nagasaka
    Judith Atz
    Flavio Solca
    Leonhard Müllauer
    Signal Transduction and Targeted Therapy, 10 (1)
  • [10] Identification of novel and known FGFR gene fusions in Chinese non-small cell lung cancer
    Zhao, W.
    Ou, Q.
    Wu, X.
    Wang, X.
    Shao, Y. W.
    ANNALS OF ONCOLOGY, 2019, 30